{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:09:16Z","timestamp":1757617756684,"version":"3.44.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00066-025-02392-1","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T06:45:52Z","timestamp":1744267552000},"page":"837-845","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intensity modulated radiation therapy in prostate cancer\u2014Better survival with higher total dose?"],"prefix":"10.1007","volume":"201","author":[{"given":"Artem","family":"Trofymov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Bschleipfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1367-5536","authenticated-orcid":false,"given":"Gerhard G.","family":"Grabenbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"2392_CR1","volume-title":"Krebs in deutschland f\u00fcr 2019\/2020","author":"Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.\u202fV","year":"2023","unstructured":"Robert Koch-Institut und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.\u202fV (2023) Krebs in deutschland f\u00fcr 2019\/2020, 14th\u00a0edn. Robert Koch-Institut, Berlin","edition":"14"},{"issue":"6","key":"2392_CR2","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray\u00a0F, Ferlay\u00a0J et\u00a0al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"key":"2392_CR3","doi-asserted-by":"crossref","unstructured":"Hamdy FC et\u00a0al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N\u00a0Engl J Med 375(15)","DOI":"10.1056\/NEJMoa1606220"},{"key":"2392_CR4","unstructured":"Mottet N et\u00a0al (2021) EAU-ESTRO-SIOG guidelines on prostate cancer. Eur Urol"},{"issue":"20","key":"2392_CR5","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1200\/JCO.2016.67.0448","volume":"34","author":"WR Lee","year":"2019","unstructured":"Lee\u00a0WR et\u00a0al (2019) Randomized phase\u00a0III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer. JCO 34(20):2325\u20132332","journal-title":"JCO"},{"issue":"5","key":"2392_CR6","first-page":"1226","volume":"100","author":"AU Kishan","year":"2018","unstructured":"Kishan\u00a0AU et\u00a0al (2018) Metastasis-free survival and overall survival with stereotactic body radiotherapy, external beam radiotherapy, and brachytherapy boost for prostate cancer: a\u00a0national cancer database analysis. Int J Radiat Oncol Biol Phys 100(5):1226\u20131235","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2392_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S1470-2045(14)70040-3","volume":"15","author":"DP Dearnaley","year":"2014","unstructured":"Dearnaley\u00a0DP et\u00a0al (2014) Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. Lancet Oncol 15(4):464\u2013473","journal-title":"Lancet Oncol"},{"issue":"1","key":"2392_CR8","first-page":"1","volume":"2","author":"DE Spratt","year":"2016","unstructured":"Spratt\u00a0DE et\u00a0al (2016) Androgen receptor activity, molecular signatures, and outcome prediction in localized prostate cancer. JAMA Oncol 2(1):1\u201310","journal-title":"JAMA Oncol"},{"issue":"50","key":"2392_CR9","first-page":"849","volume":"114","author":"B Gauter-Fleckenstein","year":"2017","unstructured":"Gauter-Fleckenstein\u00a0B, Polednik\u00a0M, Wenz\u00a0F (2017) Prostatakarzinom: strahlentherapie als kurative option. Dtsch \u00c4rztebl 114(50):849\u2013857","journal-title":"Dtsch \u00c4rztebl"},{"issue":"26","key":"2392_CR10","first-page":"4165","volume":"24","author":"MJ Zelefsky","year":"2016","unstructured":"Zelefsky\u00a0MJ et\u00a0al (2016) High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. JCO 24(26):4165\u20134170","journal-title":"JCO"},{"issue":"1","key":"2392_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijrobp.2007.06.054","volume":"70","author":"DA Kuban","year":"2008","unstructured":"Kuban\u00a0DA et\u00a0al (2008) Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70(1):67\u201374","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"2392_CR12","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","volume":"24","author":"STH Peeters","year":"2006","unstructured":"Peeters\u00a0STH, Heemsbergen\u00a0WD, Koper\u00a0PCM et\u00a0al (2006) Dose-response in radiotherapy for localized prostate cancer: results of the dutch multicenter randomized phase\u00a0III trial comparing 68\u202fGy with 78\u202fGy. JCO 24(13):1990\u20131996","journal-title":"JCO"},{"issue":"17","key":"2392_CR13","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1200\/JCO.22.02390","volume":"41","author":"DJ Krauss","year":"2023","unstructured":"Krauss\u00a0DJ, Karrison\u00a0T, Martinez\u00a0AA et\u00a0al (2023) Dose-escalated radiotherapy alone or in combination with short-term androgen deprivation for intermediate-risk prostate cancer: results of a\u00a0phase\u00a0III multi-institutional trial. JCO 41(17):3203\u20133216","journal-title":"JCO"},{"key":"2392_CR14","first-page":"2023","volume":"3","author":"S Kim","year":"2023","unstructured":"Kim\u00a0S, Kong\u00a0JH et\u00a0al (2023) Dose-escalated radiotherapy for clinically localized and locally advanced prostate cancer: a\u00a0cochrane systematic review. Cochrane Database Syst Rev 3:2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"29","key":"2392_CR15","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1200\/JCO.2018.77.9868","volume":"36","author":"KE Hoffman","year":"2018","unstructured":"Hoffman\u00a0KE, Voong\u00a0KR, Levy\u00a0LB et\u00a0al (2018) Randomized trial of hypofractionated, dose-escalated, intensity-modulated radiation therapy (IMRT) versus conventionally fractionated IMRT for localized prostate cancer. JCO 36(29):2943\u20132949","journal-title":"JCO"},{"issue":"3","key":"2392_CR16","first-page":"482","volume":"115","author":"WA Hall","year":"2023","unstructured":"Hall\u00a0WA, Tree\u00a0AC, Dearnaley\u00a0DP et\u00a0al (2023) Focal dose escalation with intensity-modulated radiotherapy in localized prostate cancer: the DELINEATE trial results. Int J Radiat Oncol Biol Phys 115(3):482\u2013491","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2392_CR17","unstructured":"Koerber SA et\u00a0al (2024) Hypofractionated external photon radiation therapy in localized prostate cancer: evaluation of acute and long-term toxicity. World J Urol 2024:"},{"issue":"8","key":"2392_CR18","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","volume":"17","author":"D Dearnaley","year":"2016","unstructured":"Dearnaley\u00a0D et\u00a0al (2016) Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5\u2011year outcomes of the randomized, non-inferiority, phase\u00a03 CHhiP trial. Lancet Oncol 17(8):1047\u20131060","journal-title":"Lancet Oncol"},{"key":"2392_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00066-023-02193-4","volume":"200","author":"SA Koerber","year":"2024","unstructured":"Koerber\u00a0SA, H\u00f6cht\u00a0S et\u00a0al (2024) Prostate cancer and elective nodal radiation therapy for cN0 and pN0\u2014a\u00a0never ending story? Strahlenther Onkol 200:181\u2013187","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"2392_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ijrobp.2021.07.004","volume":"112","author":"WA Hall","year":"2022","unstructured":"Hall\u00a0WA, Deshmukh\u00a0S, Bruner\u00a0DW et\u00a0al (2022) Quality of life implications of dose escalated external beam radiation, results of a\u00a0prospective randomized phase\u00a0III clinical trial, RTOG 0126. Int J Radiat Oncol Biol Phys 112(1):83\u201392","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"2392_CR21","first-page":"2420","volume":"27","author":"M Bolla","year":"2009","unstructured":"Bolla\u00a0M et\u00a0al (2009) Short-term androgen suppression and radiation dose escalation for intermediate- and high-risk localized prostate cancer: results of EORTC trial 22961. JCO 27(15):2420\u20132427","journal-title":"JCO"},{"issue":"3","key":"2392_CR22","first-page":"299","volume":"1","author":"TM Pisansky","year":"2015","unstructured":"Pisansky\u00a0TM et\u00a0al (2015) Duration of androgen deprivation therapy in intermediate-risk prostate cancer: a\u00a0phase\u00a03 randomized clinical trial. JAMA Oncol 1(3):299\u2013308","journal-title":"JAMA Oncol"},{"key":"2392_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41391-021-00432-2","volume":"25","author":"T Jiang","year":"2022","unstructured":"Jiang\u00a0T, Markovic\u00a0D, Patel\u00a0J et\u00a0al (2022) Radiation therapy dose and androgen deprivation therapy in localized prostate cancer: a\u00a0meta-regression of 5\u2011year outcomes in phase\u00a0III randomized controlled trials. Prostate Cancer Prostatic Dis 25:126\u2013128","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"2392_CR24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.eururo.2022.04.003","volume":"82","author":"AU Kishan","year":"2022","unstructured":"Kishan\u00a0AU, Wang\u00a0X, Sun\u00a0Y, Romero\u00a0T, Michalski\u00a0JM, Ma\u00a0TM, Feng\u00a0FY et\u00a0al (2022) High-dose radiotherapy or androgen deprivation therapy (HEAT) as treatment intensification for localized prostate cancer: An individual patient-data network meta-analysis from the MARCAP consortium. Eur Urol 82(1):42\u201349","journal-title":"Eur Urol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02392-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-025-02392-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02392-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T10:43:53Z","timestamp":1757155433000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-025-02392-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2392"],"URL":"https:\/\/doi.org\/10.1007\/s00066-025-02392-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"type":"print","value":"0179-7158"},{"type":"electronic","value":"1439-099X"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In this article, the article note was missing and should have read \u2018This paper is part of a scientific project performed at the Medical Faculty of the University of Erlangen-Nuremberg for obtaining the academic degree of Dr.med. by Artem Trofymov.\u2019.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.\u00a0Trofymov, T.\u00a0Bschleipfer, T.\u00a0Aigner and G.G.\u00a0Grabenbauer declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}